# Balance of Angiotensin II Receptors in Vessel Function After Preeclampsia

> **NCT06157580** · EARLY_PHASE1 · COMPLETED · sponsor: **Anna Stanhewicz, PhD** · enrollment: 24 (actual)

## Conditions studied

- Preeclampsia

## Interventions

- **DRUG:** Compound 21
- **DRUG:** Angiotensin II

## Key facts

- **NCT ID:** NCT06157580
- **Lead sponsor:** Anna Stanhewicz, PhD
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-08
- **Primary completion:** 2024-10-24
- **Final completion:** 2024-12-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06157580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06157580, "Balance of Angiotensin II Receptors in Vessel Function After Preeclampsia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06157580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*